Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease
Not Applicable
Completed
- Conditions
- Non-alcoholic Fatty Liver
- Interventions
- Dietary Supplement: TrehaloseOther: Placebo
- First Posted Date
- 2018-11-13
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 39
- Registration Number
- NCT03738358
Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma
Phase 2
- Conditions
- Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
- Interventions
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 79
- Registration Number
- NCT03730740
- Locations
- π°π·
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Effect of Robot Gait Training With Brain Stimulation on Gait Function in Stroke Patients
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Device: Robot gait trainingDevice: Brain stimulation
- First Posted Date
- 2018-10-16
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT03708016
- Locations
- π°π·
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer
Active, not recruiting
- Conditions
- Lung Neoplasms
- First Posted Date
- 2018-10-15
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1050
- Registration Number
- NCT03705546
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
Phase 2
Completed
- Conditions
- Type2 Diabetes MellitusRenal InsufficiencyAlbuminuria
- Interventions
- First Posted Date
- 2018-09-12
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 209
- Registration Number
- NCT03667300
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors
Phase 2
- Conditions
- Non-small Cell Lung Cancer Metastatic
- Interventions
- Drug: Pembrolizumab plus chemotherapyDrug: Placebo plus chemotherapy
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 98
- Registration Number
- NCT03656094
- Locations
- π°π·
Jong-Mu Sun, Seoul, Korea, Republic of
White Matter Integrity According to BDNF Genotype After Stroke
Completed
- Conditions
- Stroke
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 58
- Registration Number
- NCT03647787
- Locations
- π°π·
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Post-stroke Cognitive Impairment
Not Applicable
Completed
- Conditions
- Post-stroke Cognitive Impairment
- Interventions
- Device: High-frequency rTMS on left DLPFC+anodal tDCS on right DLPFCDevice: High-frequency rTMS on left DLPFC+cathodal tDCS on right DLPFCDevice: High-frequency rTMS on left DLPFC+sham tDCS on right DLPFC
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT03647319
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Mild Cognitive Impairment
Not Applicable
Completed
- Conditions
- Mild Cognitive Impairment
- Interventions
- Device: High-frequency rTMS on left DLPFC+cathodal tDCS on right DLPFCDevice: High-frequency rTMS on left DLPFC+sham tDCS on right DLPFCDevice: High-frequency rTMS on left DLPFC+anodal tDCS on right DLPFC
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT03647345
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Recruiting
- Conditions
- CholangiocarcinomaGallbladder CancerPancreas Cancer
- Interventions
- Other: Measurement of triceps skinfold thickness
- First Posted Date
- 2018-08-20
- Last Posted Date
- 2023-08-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1000
- Registration Number
- NCT03637569
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath